Showing results (2061-2070 of 2,329) with videos related to
Sort By:
Pageof 233
JCI Insight|August 9, 2021
Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse modelClaudia Milazzo, Edwin J Mientjes, Ilse Wallaard, et al.Oncogene|September 28, 2005
Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinomaC T Miller, L Lin, A M Casper, et al.International Journal of Toxicology|November 1, 2005
Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after oral administration--part ICarla E Torrey, Henry G Wall, James A Campbell, et al.Nature Communications|July 29, 2021
Engineering single-atomic ruthenium catalytic sites on defective nickel-iron layered double hydroxide for overall water splittingPanlong Zhai, Mingyue Xia, Yunzhen Wu, et al.Nature Communications|October 28, 2018
Deconvolution of octahedral Pt3Ni nanoparticle growth pathway from in situ characterizationsXiaochen Shen, Changlin Zhang, Shuyi Zhang, et al.Sleep Medicine|May 23, 2022
Translation, cross-cultural adaptation, and psychometric properties of the Hausa version of the Insomnia Severity Index among internally displaced persons in AfricaD Salihu, E M L Wong, R Y C Kwan, et al.Journal of Medical Entomology|July 9, 2019
Identification of Host Blood Meals of Mosquitoes (Diptera: Culicidae) Collected at the Aripo Savannas Scientific Reserve in Trinidad, West IndiesDavid S Kang, Ray Martinez, Aliya Hosein, et al.Journal of the American Chemical Society|January 22, 2014
In situ optical and structural studies on photoluminesence quenching in CdSe/CdS/Au heterostructuresArnaud Demortière, Richard D Schaller, Tao Li, et al.Scientific Reports|August 12, 2023
Towards data-driven biopsychosocial classification of non-specific chronic low back pain: a pilot studyScott D Tagliaferri, Patrick J Owen, Clint T Miller, et al.Pediatric Blood & Cancer|August 10, 2011
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overloadRussell E Ware, William H Schultz, Nancy Yovetich, et al.Pageof 233